THE ONCOLOGY INSTITUTE INC. - COMMON STOCK

The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call

19 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023

16 Mar 2023 19:08:44 By Nasdaq GlobeNewswire

The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023

09 Mar 2023 15:20:01 By Nasdaq GlobeNewswire

The Oncology Institute to Participate at Upcoming Investor Conferences

28 Feb 2023 07:00:01 By Nasdaq GlobeNewswire

The Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call

16 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

The Oncology Institute Expands Into Chino, CA

19 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

The Oncology Institute Rebrands Clinical Trials Division

15 Dec 2022 07:00:02 By Nasdaq GlobeNewswire

The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa

22 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance

09 Nov 2022 15:05:02 By Nasdaq GlobeNewswire

The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference

01 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call

19 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

The Oncology Institute Executives to Speak at Key Industry Conferences in Q4

17 Oct 2022 15:05:00 By Nasdaq GlobeNewswire

The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials

11 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

The Oncology Institute Expands into South Florida

06 Oct 2022 07:00:02 By Nasdaq GlobeNewswire

The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib

29 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

The Oncology Institute Appoints Two New Board Members

22 Sep 2022 15:05:00 By Nasdaq GlobeNewswire

The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium

15 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

The Oncology Institute Becomes Certified as a Patient Safety Organization

12 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms

22 Aug 2022 07:00:00 By Nasdaq GlobeNewswire

The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day

16 Aug 2022 07:00:01 By Nasdaq GlobeNewswire